EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Ability of Clinically Relevant Chemotherapeutics to Induce Immunogenic Cell Death in Squamous Cell Carcinoma

Zhenjie He, Xinming Jing, Xiaoyan Dai, Lingbo Bao, Xiao Yang, Yanli Xiong, Mengxia Li

Frontiers in Bioscience-Landmark · 2024

DOI: 10.31083/j.fbl2904158 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Bioscience-Landmark, 2024. Verfasst von Zhenjie He und 6 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Center of Daping Hospital, Third Military Medical University, 400038 Chongqing, China. Hauptthemen laut MEDLINE: Immunogenic Cell Death, Carcinoma, Squamous Cell, HMGB1 Protein, Calreticulin. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Immunogenic cell death (ICD) is a crucial mechanism for triggering the adaptive immune response in cancer patients. Damage-associated molecular patterns (DAMPs) are critical factors in the detection of ICD. Chemotherapeutic drugs can cause ICD and the release of DAMPs. The aim of this study was to assess the potential for paclitaxel and platinum-based chemotherapy regimens to induce ICD in squamous cell carcinoma (SCC) cell lines. In addition, we examined the immunostimulatory effects of clinically relevant chemotherapeutic regimens utilized in the treatment of SCC.

Methods

We screened for differentially expressed ICD markers in the supernatants of three SCC cell lines following treatment with various chemotherapeutic agents. The ICD markers included Adenosine Triphosphate (ATP), Calreticulin (CRT), Annexin A1 (ANXA 1), High Mobility Group Protein B1 (HMGB1), and Heat Shock Protein 70 (HSP70). A vaccination assay was also employed in C57BL/6J mice to validate our in vitro findings. Lastly, the levels of CRT and HMGB1 were evaluated in Serum samples from SCC patients.

Results

Addition of the chemotherapy drugs cisplatin (DDP), carboplatin (CBP), nedaplatin (NDP), oxaliplatin (OXA) and docetaxel (DOC) increased the release of ICD markers in two of the SCC cell lines. Furthermore, mice that received vaccinations with cervical cancer cells treated with DDP, CBP, NDP, OXA, or DOC remained tumor-free. Although CBP induced the release of ICD-associated molecules in vitro, it did not prevent tumor growth at the vaccination site in 40% of mice. In addition, both in vitro and in vivo results showed that paclitaxel (TAX) and LBP did not induce ICD in SCC cells.

Conclusion

The present findings suggest that chemotherapeutic agents can induce an adjuvant effect leading to the extracellular release of DAMPs. Of the agents tested here, DDP, CBP, NDP, OXA and DOC had the ability to act as inducers of ICD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunogenic Cell DeathCarcinoma, Squamous CellHMGB1 ProteinCalreticulinCisplatinAntineoplastic AgentsPaclitaxelMice, Inbred C57BLOrganoplatinum CompoundsAnimalsHumansCell Line, TumorOxaliplatinMiceCarboplatinDocetaxelFemaleAdenosine TriphosphateHSP70 Heat-Shock ProteinsAnnexin A1

Stichwörter der Autor:innen

chemotherapydamage-associated molecular patternimmunogenic cell deathsquamous carcinoma

Substanzen

HMGB1 ProteinCalreticulinCisplatinAntineoplastic AgentsPaclitaxelOrganoplatinum CompoundsOxaliplatinCarboplatinDocetaxelnedaplatin

Autor:innen und Institutionen

  • Cancer Center of Daping Hospital, Third Military Medical University, 400038 Chongqing, China.
  • Department of Oncology, General Hospital of Western Theatre Command, 610000 Chengdu, Sichuan, China.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

He, Z., Jing, X., Dai, X., Bao, L., Yang, X., Xiong, Y., & Li, M. (2024). The Ability of Clinically Relevant Chemotherapeutics to Induce Immunogenic Cell Death in Squamous Cell Carcinoma. Frontiers in Bioscience-Landmark. https://doi.org/10.31083/j.fbl2904158

Vancouver

He Z, Jing X, Dai X, Bao L, Yang X, Xiong Y, et al. The Ability of Clinically Relevant Chemotherapeutics to Induce Immunogenic Cell Death in Squamous Cell Carcinoma. Frontiers in Bioscience-Landmark. 2024. doi:10.31083/j.fbl2904158

BibTeX
@article{He2024,
  author = {He, Zhenjie and Jing, Xinming and Dai, Xiaoyan and Bao, Lingbo and Yang, Xiao and Xiong, Yanli and Li, Mengxia},
  title = {The Ability of Clinically Relevant Chemotherapeutics to Induce Immunogenic Cell Death in Squamous Cell Carcinoma},
  journal = {Frontiers in Bioscience-Landmark},
  year = {2024},
  doi = {10.31083/j.fbl2904158}
}
Kostenlos starten →